Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD)

Psychopharmacology

Volumn 204, Issue 1, 2009, Pages 73-83

  Kollins, Scott H ^a   English, Joseph ^a   Robinson, Rachel ^a   Hallyburton, Matt ^a   Chrisman, Allan K ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Abuse potential; ADHD; Drug reinforcement; Methylphenidate; Subjective effects

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; AROUSAL; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; MALE; MENTAL CONCENTRATION; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHYLPHENIDATE; QUESTIONNAIRES; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 67349182160     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1439-6     Document Type: Article

References (52)

1. ME Abreu RR Griffiths 1996 Drug tasting may confound human drug discrimination studies Psychopharmacology (Berl) 125 255 257 (Pubitemid 26184811)
2. CG Berbatis VB Sunderland M Bulsara 2002 Licit psychostimulant consumption in Australia, 1984-2000: international and jurisdictional comparison Med J Aust 177 539 543 (Pubitemid 35422816)
3. J Brady 1988 The reinforcing functions of drugs and assessment of abuse liability NIDA Res Monogr 81 440 456 (Pubitemid 18169829)
4. LD Chait 1994 Reinforcing and subjective effects of methylphenidate in humans Behav Pharmacol 5 281 288 (Pubitemid 24217290)
5. KA Cheon YH Ryu YK Kim K Namkoong CH Kim JD Lee 2003 Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder Eur J Nucl Med Mol Imaging 30 306 311 (Pubitemid 36686852)
6. Conners CK, Erhardt D, Sparrow EP (1998) Conners Adult ADHD Rating Scale. Multi-Health Systems, Inc., Multi-Health Systems, Inc.
7. DD Dougherty AA Bonab TJ Spencer SL Rauch BK Madras AJ Fischman 1999 Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 2132 2133 (Pubitemid 30008900)
8. S Dresel J Krause KH Krause C LaFougere K Brinkbaumer HF Kung K Hahn K Tatsch 2000 Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment Eur J Nucl Med 27 1518 1524
9. J Elia PJ Ambrosini JL Rapoport 1999 Treatment of attention-deficit- hyperactivity disorder N Engl J Med 340 780 788
10. Epstein JN, Johnston DE, Conners CK (2000) Conners Adult ADHD Interview for DSM-IV. Multi-Health Systems, Multi-Health Systems
11. First MB, Gibbon M, Spitzer RL, Williams JBW (1996) User's guide for the Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version. Biometrics Research Department, Biometrics Research Department
12. Y Fogelman E Kahan 2001 Methylphenidate use for attention deficit hyperactivity disorder in northern Israel-a controversial issue Isr Med Assoc J 3 925 927 (Pubitemid 34082805)
13. EM Fredericks SH Kollins 2004 Assessing methylphenidate preference in ADHD patients using a choice procedure Psychopharmacology (Berl) 175 391 398 (Pubitemid 39362036)
14. EJ Garland 1998 Intranasal abuse of prescribed methylphenidate [letter] J Am Acad Child Adolesc Psych 37 1242 1243 (Pubitemid 28550712)
15. LS Goldman M Genel RJ Bezman PJ Slanetz 1998 Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association JAMA 279 1100 1107 (Pubitemid 28421652)
16. Grace AA (2001) Psychostimulant actions on dopamine and limbic system function: Relevance to the pathophysiology and treatment of ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX (eds) Stimulant Drugs & ADHD: Basic and Clinical Neuroscience. Oxford University Press, Oxford, pp 134-157
17. FJ Ivis EM Adlaf 1999 Prevalence of methylphenidate use among adolescents in Ontario Can J Public Health 90 309 312
18. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2006) Monitoring the Future national survey results on drug use, 1975-2005. Volume I: Secondary school students (NIH Publication No. 06-5883). National Institute on Drug Abuse, Bethesda, MD
19. TH Kelly G Robbins CA Martin MT Fillmore SD Lane NG Harrington CR Rush 2006 Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status Psychopharmacology (Berl) 189 17 25 (Pubitemid 44607256)
20. RC Kessler L Adler R Barkley J Biederman CK Conners O Demler SV Faraone LL Greenhill MJ Howes K Secnik T Spencer TB Ustun EE Walters AM Zaslavsky 2006 The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 163 716 723 (Pubitemid 44464584)
21. SH Kollins 2003 Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient J Clin Psychiatry 64 Suppl 11 14 18 (Pubitemid 37169644)
22. SH Kollins CR Rush 1999 Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans Pharmacol Biochem Behav 64 319 329 (Pubitemid 29438617)
23. SH Kollins CR Rush PJ Pazzaglia JA Ali 1998 Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate Exp Clin Psychopharmacol 6 367 374 (Pubitemid 29001514)
24. SH Kollins EK [tmp] MacDonald CR Rush 2001 Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review Pharmacol Biochem Behav 68 611 627 (Pubitemid 32452420)
25. KH Krause SH Dresel J Krause HF Kung K Tatsch 2000 Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett 285 107 110 (Pubitemid 30227631)
26. KH Krause SH Dresel J Krause HF Kung K Tatsch M Ackenheil 2002 Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder Int J Neuropsychopharmacol 5 111 113 (Pubitemid 34662972)
27. KH Krause SH Dresel J Krause C la Fougere M Ackenheil 2003 The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder Neurosci Biobehav Rev 27 605 613 (Pubitemid 37414909)
28. LA Kroutil DL Van Brunt MA Herman-Stahl DC Heller RM Bray MA Penne 2006 Nonmedical use of prescription stimulants in the United States Drug Alcohol Depend 84 135 143 (Pubitemid 44160579)
29. R Larisch W Sitte C Antke S Nikolaus M Franz W Tress HW Muller 2006 Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder Nucl Med Commun 27 267 270 (Pubitemid 44391815)
30. B Levine YH Caplan G Kauffman 1986 Fatality resulting from methylphenidate overdose J Anal Toxicol 10 209 210 (Pubitemid 17106466)
31. SJ Lin SY Crawford PL Lurvey 2005 Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan Soc Sci Med 60 617 626 (Pubitemid 39506810)
32. E [tmp] MacDonald Fredericks SH Kollins 2005 A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder J Child Adolesc Psychopharmacol 15 729 741 (Pubitemid 41567145)
33. WR Martin JW Sloan JD Sapira DR Jasinski 1971 Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin Pharmacol Ther 12 2 245 258
34. W Massello III DA Carpenter 1999 A fatality due to the intranasal abuse of methylphenidate (Ritalin) J Forensic Sci 44 220 221 (Pubitemid 29035798)
35. SE [tmp] McCabe JR Knight CJ Teter H Wechsler 2005 Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey Addiction 100 96 106 (Pubitemid 40516844)
36. AH Oliveto WK Bickel JR Hughes PJ Shea ST Higgins JW Fenwick 1992 Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports J Pharmacol Exp Ther 261 885 894
37. KA Perkins JE Grobe A Caggiula AS Wilson RL Stiller 1997 Acute reinforcing effects of low-dose nicotine nasal spray in humans Pharmacol Biochem Behav 56 235 241 (Pubitemid 27115910)
38. JL Rapoport MS Buchsbaum H Weingartner TP Zahn C Ludlow EJ Mikkelsen 1980 Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men Arch Gen Psychiatry 37 933 943
39. LM Robison DA Sclar TL Skaer RS Galin 1999 National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995 Clin Pediatr (Phila) 38 209 217 (Pubitemid 29186373)
40. T Roehrs K Papineau L Rosenthal T Roth 1999 Sleepiness and the reinforcing and subjective effects of methylphenidate Exp Clin Psychopharmacol 7 145 150 (Pubitemid 29228299)
41. E Romano RH Baillargeon HX Wu P Robaey RE Tremblay 2002 Prevalence of methylphenidate use and change over a two-year period: a nationwide study of 2- to 11-year-old Canadian children J Pediatr 141 71 75
42. CR Rush WD Essman CA Simpson RW Baker 2001 Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans J Clin Psychopharmacol 21 273 286 (Pubitemid 32452932)
43. DJ Safer JM Zito EM Fine 1996 Increased methylphenidate usage for attention deficit disorder in the 1990s Pediatrics 98 1084 1088 (Pubitemid 26399270)
44. MV Solanto 2002 Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research Behav Brain Res 130 65 71 (Pubitemid 34195322)
45. TJ Spencer J Biederman BK Madras SV Faraone DD Dougherty AA Bonab AJ Fischman 2005 In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter Biol Psychiatry 57 1293 1300 (Pubitemid 40798548)
46. TJ Spencer J Biederman PE Ciccone BK Madras DD Dougherty AA Bonab E Livni DA Parasrampuria AJ Fischman 2006 PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate Am J Psychiatry 163 387 395 (Pubitemid 44469379)
47. WW Stoops PE Glaser CR Rush 2003 Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis Drug Alcohol Depend 71 179 186 (Pubitemid 37289027)
48. WW Stoops PE Glaser MT Fillmore CR Rush 2004 Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans J Psychopharmacol 18 534 543 (Pubitemid 39665121)
49. WW Stoops JA Lile MT Fillmore PE Glaser CR Rush 2005 Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration Psychopharmacology (Berl) 177 349 355 (Pubitemid 40137296)
50. WW Stoops JA Lile CG Robbins CA Martin CR Rush TH Kelly 2007 The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status Addict Behav 32 1177 1188 (Pubitemid 46497548)
51. ND Volkow GJ Wang J Newcorn JS Fowler F Telang MV Solanto J Logan C Wong Y Ma JM Swanson K Schulz K Pradhan 2007 Brain dopamine transporter levels in treatment and drug naive adults with ADHD Neuroimage 34 1182 1190 (Pubitemid 46394475)
52. JM Zito DJ Safer S dosReis JF Gardner M Boles F Lynch 2000 Trends in the prescribing of psychotropic medications to preschoolers JAMA 283 1025 1030 (Pubitemid 30112216)